Literature DB >> 21696664

Achieving faster recanalization times by IA thrombolysis in acute ischemic stroke: where should we direct our efforts?

M Eesa1, B K Menon, M D Hill, A Demchuk, M Goyal.   

Abstract

Faster recanalization correlates with better outcomes in acute ischemic stroke. We analyzed times from arrival in ER to end of treatment in patients undergoing endovascular treatment for acute ischemic stroke at our institution.We retrospectively studied patients who underwent IA procedures for stroke from 2005 to 2009 noting the times of arrival to ER, CT scan, arrival to DSA, arterial puncture and recanalization from our endovascular database. A subgroup analysis was performed based on administration of GA, use of mechanical devices and whether the procedure was performed during regular hours or after hours.Of 101 patients, 53 were male, with a median age of 66 years (range 18-87). There were 81 anterior circulation strokes. Median ER to CT time was 22 min (2-1025), CT to DSA arrival time 80 min (range 4-990), DSA arrival to puncture time 24 min (range 0-75) and puncture to recanalization time 84 min (range 11-206). 23.3% of patients had an ER to CT time interval of > 60 min and 71.3 % had a CT to DSA time interval of > 60 min contributing to significant in-hospital delays. For subgroup analysis the Mann-Whitney test was used. No significant differences in CT to DSA arrival (p=0.8), DSA arrival to puncture (p=0.1) and puncture to recanalization (p=0.59) times were noted between patients with and without GA. No significant difference was noted in puncture to recanalization times with or without device (p=0.78). 39 cases were done during regular (R) hours and 62 after (A) hours. Median ER to CT time (R=18 min, A = 27 min, p 0.02), CT to DSA arrival time (R=64 min, A=90 min, p 0.004) and DSA arrival to puncture time (R=18 min, A=25 min, p 0.003) was significantly higher after hours.ER to CT and CT to DSA arrival times in patients undergoing endovascular stroke therapy show wide variability and therefore, considerable scope for reduction. Time differences during regular and after hours should serve as a reminder to make efforts to reduce overall ischemic times in spite of staffing patterns and resource availability.

Entities:  

Mesh:

Year:  2011        PMID: 21696664      PMCID: PMC3287276          DOI: 10.1177/159101991101700215

Source DB:  PubMed          Journal:  Interv Neuroradiol        ISSN: 1591-0199            Impact factor:   1.610


  19 in total

1.  Early recanalisation in acute ischaemic stroke saves tissue at risk defined by MRI.

Authors:  O Jansen; P Schellinger; J Fiebach; W Hacke; K Sartor
Journal:  Lancet       Date:  1999-06-12       Impact factor: 79.321

2.  Hemorrhagic transformation in focal cerebral ischemia: influence of time to artery reopening and tissue plasminogen activator.

Authors:  S C Fagan; J H Garcia
Journal:  Pharmacotherapy       Date:  1999-02       Impact factor: 4.705

3.  Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism.

Authors:  A Furlan; R Higashida; L Wechsler; M Gent; H Rowley; C Kase; M Pessin; A Ahuja; F Callahan; W M Clark; F Silver; F Rivera
Journal:  JAMA       Date:  1999-12-01       Impact factor: 56.272

4.  Practice advisory: thrombolytic therapy for acute ischemic stroke--summary statement. Report of the Quality Standards Subcommittee of the American Academy of Neurology.

Authors: 
Journal:  Neurology       Date:  1996-09       Impact factor: 9.910

5.  PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. PROACT Investigators. Prolyse in Acute Cerebral Thromboembolism.

Authors:  G J del Zoppo; R T Higashida; A J Furlan; M S Pessin; H A Rowley; M Gent
Journal:  Stroke       Date:  1998-01       Impact factor: 7.914

6.  Tissue plasminogen activator for acute ischemic stroke.

Authors: 
Journal:  N Engl J Med       Date:  1995-12-14       Impact factor: 91.245

Review 7.  Neuroprotection for acute stroke: making clinical trials work.

Authors:  K W Muir; D G Grosset
Journal:  Stroke       Date:  1999-01       Impact factor: 7.914

8.  Factors associated with delayed admission to hospital and in-hospital delays in acute stroke and TIA: a prospective, multicenter study.Seek- Medical-Attention-in-Time Study Group.

Authors:  P Wester; J Rådberg; B Lundgren; M Peltonen
Journal:  Stroke       Date:  1999-01       Impact factor: 7.914

9.  The ECASS 3-hour cohort. Secondary analysis of ECASS data by time stratification. ECASS Study Group. European Cooperative Acute Stroke Study.

Authors:  T Steiner; E Bluhmki; M Kaste; D Toni; P Trouillas; R von Kummer; W Hacke
Journal:  Cerebrovasc Dis       Date:  1998 Jul-Aug       Impact factor: 2.762

10.  Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials.

Authors:  Werner Hacke; Geoffrey Donnan; Cesare Fieschi; Markku Kaste; Rüdiger von Kummer; Joseph P Broderick; Thomas Brott; Michael Frankel; James C Grotta; E Clarke Haley; Thomas Kwiatkowski; Steven R Levine; Chris Lewandowski; Mei Lu; Patrick Lyden; John R Marler; Suresh Patel; Barbara C Tilley; Gregory Albers; Erich Bluhmki; Manfred Wilhelm; Scott Hamilton
Journal:  Lancet       Date:  2004-03-06       Impact factor: 79.321

View more
  11 in total

1.  A systems approach towards intra-arterial management of acute ischemic stroke: need for novel outcome measures and a focus on sequence rather than steps.

Authors:  B K Menon; M Goyal
Journal:  Interv Neuroradiol       Date:  2011-10-17       Impact factor: 1.610

2.  Wide Variability in Prethrombectomy Workflow Practices in the United States: A Multicenter Survey.

Authors:  A P Kansagra; G C Meyers; M S Kruzich; D T Cross; C J Moran
Journal:  AJNR Am J Neuroradiol       Date:  2017-09-21       Impact factor: 3.825

3.  Intra-arterial therapy for acute ischemic stroke: a golden age.

Authors:  Pedro Telles Cougo-Pinto; Ronil V Chandra; Claus Z Simonsen; Joshua A Hirsch; Thabele Leslie-Mazwi
Journal:  Curr Treat Options Neurol       Date:  2015-07       Impact factor: 3.598

4.  Availability of tracheal shift in the chest X-ray image as pre-treatment evaluation of mechanical thrombectomy.

Authors:  Fukutaro Ohgaki; Nobuyuki Shimizu; Jun Suenaga; Kensuke Tateishi; Naoki Ikegaya; Ryosuke Suzuki; Koji Yamamura; Tetsuya Yamamoto
Journal:  Neuroradiol J       Date:  2022-05-17

5.  Society of Vascular and Interventional Neurology (SVIN) Stroke Interventional Laboratory Consensus (SILC) Criteria: A 7M Management Approach to Developing a Stroke Interventional Laboratory in the Era of Stroke Thrombectomy for Large Vessel Occlusions.

Authors:  Tanzila Shams; Osama Zaidat; Dileep Yavagal; Andrew Xavier; Tudor Jovin; Vallabh Janardhan
Journal:  Interv Neurol       Date:  2016-02-26

6.  The Evolution of Mechanical Thrombectomy for Acute Stroke.

Authors:  Feras Akbik; Joshua A Hirsch; Pedro Telles Cougo-Pinto; Ronil V Chandra; Claus Z Simonsen; Thabele Leslie-Mazwi
Journal:  Curr Treat Options Cardiovasc Med       Date:  2016-05

7.  Reducing door-to-puncture times for intra-arterial stroke therapy: a pilot quality improvement project.

Authors:  Brijesh P Mehta; Thabele M Leslie-Mazwi; Ronil V Chandra; Donnie L Bell; Chung-Huan J Sun; Joshua A Hirsch; James D Rabinov; Natalia S Rost; Lee H Schwamm; Joshua N Goldstein; Wilton C Levine; Rishi Gupta; Albert J Yoo
Journal:  J Am Heart Assoc       Date:  2014-11-11       Impact factor: 5.501

8.  Consensus Statements by Korean Society of Interventional Neuroradiology and Korean Stroke Society: Hyperacute Endovascular Treatment Workflow to Reduce Door-to-Reperfusion Time.

Authors:  Dae-Hyun Kim; Byungjun Kim; Cheolkyu Jung; Hyo Suk Nam; Jin Soo Lee; Jin Woo Kim; Woong Jae Lee; Woo-Keun Seo; Ji-Hoe Heo; Seung Kug Baik; Byung Moon Kim; Joung-Ho Rha
Journal:  J Korean Med Sci       Date:  2018-04-26       Impact factor: 2.153

9.  Recommendations on angiographic revascularization grading standards for acute ischemic stroke: a consensus statement.

Authors:  Osama O Zaidat; Albert J Yoo; Pooja Khatri; Thomas A Tomsick; Rüdiger von Kummer; Jeffrey L Saver; Michael P Marks; Shyam Prabhakaran; David F Kallmes; Brian-Fred M Fitzsimmons; J Mocco; Joanna M Wardlaw; Stanley L Barnwell; Tudor G Jovin; Italo Linfante; Adnan H Siddiqui; Michael J Alexander; Joshua A Hirsch; Max Wintermark; Gregory Albers; Henry H Woo; Donald V Heck; Michael Lev; Richard Aviv; Werner Hacke; Steven Warach; Joseph Broderick; Colin P Derdeyn; Anthony Furlan; Raul G Nogueira; Dileep R Yavagal; Mayank Goyal; Andrew M Demchuk; Martin Bendszus; David S Liebeskind
Journal:  Stroke       Date:  2013-08-06       Impact factor: 7.914

10.  Clinical Outcomes of Endovascular Thrombectomy in Tissue Plasminogen Activator versus Non-Tissue Plasminogen Activator Patients at Primary Stroke Care Centers.

Authors:  Gregory Imbarrato; Joshua Bentley; Ajeet Gordhan
Journal:  J Neurosci Rural Pract       Date:  2018 Apr-Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.